ZA895187B - Method of modulating virus-host cell interactions using carbohydrates and carbohydrate derivatives - Google Patents

Method of modulating virus-host cell interactions using carbohydrates and carbohydrate derivatives

Info

Publication number
ZA895187B
ZA895187B ZA895187A ZA895187A ZA895187B ZA 895187 B ZA895187 B ZA 895187B ZA 895187 A ZA895187 A ZA 895187A ZA 895187 A ZA895187 A ZA 895187A ZA 895187 B ZA895187 B ZA 895187B
Authority
ZA
South Africa
Prior art keywords
virus
cells
cyclodextrins
chemically modified
inhibiting
Prior art date
Application number
ZA895187A
Other languages
English (en)
Inventor
Steven A Roth
A Roth Steven
George Farnbach
Farnbach George
Mark I Greene
I Greene Mark
Paul B Weisz
B Weisz Paul
David B Weiner
B Weiner David
William V Williams
V Williams William
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of ZA895187B publication Critical patent/ZA895187B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA895187A 1988-07-07 1989-07-07 Method of modulating virus-host cell interactions using carbohydrates and carbohydrate derivatives ZA895187B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21617688A 1988-07-07 1988-07-07
US37300589A 1989-06-28 1989-06-28

Publications (1)

Publication Number Publication Date
ZA895187B true ZA895187B (en) 1990-04-25

Family

ID=26910735

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895187A ZA895187B (en) 1988-07-07 1989-07-07 Method of modulating virus-host cell interactions using carbohydrates and carbohydrate derivatives

Country Status (10)

Country Link
EP (1) EP0423240B1 (pt)
JP (1) JPH04500456A (pt)
KR (1) KR900702005A (pt)
AT (1) ATE129897T1 (pt)
AU (1) AU636850B2 (pt)
DE (1) DE68924774T2 (pt)
IE (1) IE75688B1 (pt)
PT (1) PT91088B (pt)
WO (1) WO1990000596A1 (pt)
ZA (1) ZA895187B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2067854T3 (es) * 1990-03-15 1995-04-01 Tanabe Seiyaku Co Polisulfato de derivado de ciclodextrina y procedimiento para preparar el mismo.
US5248675A (en) * 1990-03-15 1993-09-28 Tanabe Seiyaku Co., Ltd. Polysulfate of cyclodextrin derivative and process for preparing the same
GB9020872D0 (en) * 1990-09-25 1990-11-07 Ml Lab Plc Pharmaceutical compositions and use thereof
FR2669535A1 (fr) * 1990-11-26 1992-05-29 Medgenix Group Sa Utilisation a titre de medicament de macromolecules polysulfonees.
US5312837A (en) * 1991-01-29 1994-05-17 Genelabs Technologies, Inc. Method of treating viral infections with aryl macrocyclic compounds
JP2556236B2 (ja) * 1991-08-29 1996-11-20 田辺製薬株式会社 β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
AU4803393A (en) * 1992-08-06 1994-03-03 Genelabs Technologies, Inc. Inhibition and treatment of infection by enveloped virus with calix(n) arene compounds
DE9316320U1 (de) * 1993-10-20 1994-01-20 Beni Med Natuerliche Heilmitte Kosmetische Zubereitung in Form von Lippenstiften mit antiviraler Wirkung
US5691316A (en) * 1994-06-01 1997-11-25 Hybridon, Inc. Cyclodextrin cellular delivery system for oligonucleotides
US6835717B2 (en) 2000-03-08 2004-12-28 The Johns Hopkins University School Of Medicine β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
DE10203999A1 (de) * 2002-02-01 2003-08-14 Nutricia Nv Cycloglycane
BE1030002B1 (fr) 2021-12-29 2023-09-01 Aquilon Pharmaceuticals Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire
WO2023118014A1 (en) 2021-12-20 2023-06-29 Aquilon Pharmaceuticals Inhalable compositions comprising a complex of hpbcd and budesonide or ciclesonide for the treatment or prevention of a respiratory viral disease or lipopolysaccharide-induced inflammation, in particular lipopolysaccharide-induced inflammation associated with a respiratory viral disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses

Also Published As

Publication number Publication date
DE68924774T2 (de) 1996-05-02
KR900702005A (ko) 1990-12-05
PT91088B (pt) 1995-01-31
AU636850B2 (en) 1993-05-13
EP0423240A1 (en) 1991-04-24
IE75688B1 (en) 1997-09-10
ATE129897T1 (de) 1995-11-15
PT91088A (pt) 1990-02-08
WO1990000596A1 (en) 1990-01-25
EP0423240B1 (en) 1995-11-08
AU4044389A (en) 1990-02-05
IE892183L (en) 1990-01-07
EP0423240A4 (en) 1992-07-22
JPH04500456A (ja) 1992-01-30
DE68924774D1 (de) 1995-12-14

Similar Documents

Publication Publication Date Title
ZA895187B (en) Method of modulating virus-host cell interactions using carbohydrates and carbohydrate derivatives
DK0934310T3 (da) Thiosyreafledte, monocykliske forbindelser som antikoaguleringsmidler
MY121999A (en) Inclusion complexes of aryl-heterocyclic salts
NO944764D0 (no) Inklusjonskomplekser i vandige opplösninger av benzotiofenforbindelser med vannopplöselige cyklodekstriner og farmasöytiske formuleringer og fremgangsmåter
DE69023957D1 (de) Sulfatierte Polysaccharide, Antikoagulierungs- und Antikomplementärmittel, hergestellt aus Fukanen aus braunen Algen, und Verfahren zu deren Herstellung.
NL191308B (nl) Gelyofiliseerd, na oplossing injecteerbaar preparaat dat een antracycline-glycoside bevat, alsmede werkwijze voor de bereiding van een injecteerbare oplossing van een antracycline-glycoside.
TR25385A (tr) Nem ile sertlesen bir bilesenli polisilokzan bilesigi
DE60022380D1 (de) Verwendung von einem trifluridin derivat allein oder in kombination mit einem thymidin-phosphorylase-hemmer zur behandlung von hiv
AU2233088A (en) Method and apparatuses for sanitizing materials utilizing superheated steam
ATE376445T1 (de) Synergistische hemmung von viralreplikation durch langkettigen kohlenwasserstoffe und nucleosid- analoge
DK11889D0 (da) Tyggegummi med styret soedhed
KR890016922A (ko) 복합 감미료
HUT68239A (en) Process for producing inclusion complexes of nimesulide alkali salts with cyclodextrins or cyclodextrin derivatives and pharmaceutical preparations containing them
DK640587A (da) Cytostatisk virksomme anthracyclinderivater cytostatisk virksomme anthracyclinderivater
AU1720697A (en) Nutrient composition for exercise
KR880005144A (ko) 올리고당의 제조법
EP0348910A3 (en) 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
ES2174955T3 (es) Sulfatacion regioselectiva.
SE8602971D0 (sv) Low calorie bulking agent, method for production thereof, and use thereof
NO20012631L (no) Trebevarende formuleringer
AR019701A1 (es) Compuestos derivados de alfa-d-xilosa, preparacion y su utilizacion en terapeutica
BR9915284A (pt) Método de tratamento
徐道义 STABILITY OF LINEAR SYSTEMS WITH TIME-VARYING DELAYS
ATE270542T1 (de) Zusammensetzung zur verhinderung der keimbindung
DE69936405D1 (de) Verwendung einer Zusammensetzung um das Anhaften von Keimen auf der Haut zu verhindern